To view this email as a web page, click here

Today's Rundown

Featured Story

After COVID-19 spotlighted supply chain weaknesses, Biden unveils plan to resurrect U.S. drug manufacturing

After shining a spotlight on America’s supply chains, including those for drugs and pharmaceutical ingredients, the Biden administration has revelations to share—and a sweeping strategy to boost domestic drug production. The plan includes a new public-private manufacturing consortium, investments in advanced production technologies and more.

read more

Top Stories

Vizient report expects patient volumes to fully rebound in 2022 after COVID-19 losses

A new report projects that patient volumes will surpass pre-pandemic levels in 2022 but emergency department visits are expected to face a prolonged decline.

read more

As COVID-19 exacerbates violence in the workplace, one health system is using discreet wearables to protect staff

Bassett Healthcare Network will be the first system to deploy the Strongline Staff Safety System across its entire caregiver workforce. The deployment comes as healthcare executives, legislators and labor groups alike call for an increased focus on healthcare workers' safety.

read more

COVID-19 tracker: Study finds no additional benefit from vaccination among those previously infected

A study by the Cleveland Clinic showed that people who were infected with COVID-19 and later were vaccinated received no additional protection. Australia will not follow the lead of Canada, which is offering people a mix of adenovirus and mRNA vaccines. And more headlines.

read more

LetsGetChecked hits unicorn status with $150M to grow at-home testing, telehealth services

The at-home diagnostics provider closed its high-flying series D with support from a handful of longtime backers that included Illumina Ventures, UnitedHealth’s Optum Ventures and golfer Rory McIlroy, through his own Symphony Ventures.

read more

Boehringer Ingelheim taps into Lifebit's AI for global disease surveillance

Boehringer Ingelheim's ambitious project with AI developer Lifebit aims to use natural language processing to help chart a course among new global outbreaks of infectious diseases.

read more

CMO Selkirk blueprints $90M factory to help bring injectable drug manufacturing stateside

While Selkirk's 2018 launch predates COVID-19, the CMO is pitching itself as another champion in the quest to “onshore” drug manufacturing capabilities in the U.S. As part of that effort, the company unveiled a $90 million plant pegged to shore up local capacity for injectable drugs.

read more